Skip to main content
Premium Trial:

Request an Annual Quote

CogenDx DxWound

CogenDx has launched its newest test offering, DxWound. The test uses DNA-based technology to provide sensitive detection of an array of microbes, including aerobic and anaerobic bacteria, fungi, and antibiotic resistance genes. Test results equip clinicians to rapidly and accuratley identify pathogens causing infections and choose antibiotics with improved likelihood for success. DxWound utilizes a swab to collect microbial DNA directly from the infection site and leverages a transport buffer that preserves the wound microbiome during specimen transit. Test results are delivered the next business day from specimen receipt at the laboratory. 

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.